Cerity Partners LLC Bicycle Therapeutics PLC Transaction History
Cerity Partners LLC
- $55.1 Billion
- Q2 2025
A detailed history of Cerity Partners LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Cerity Partners LLC holds 14,350 shares of BCYC stock, worth $103,607. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,350
Previous 13,350
7.49%
Holding current value
$103,607
Previous $113,000
12.39%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
43.8MCall Options Held
51.2KPut Options Held
31.5K-
Baker Bros. Advisors LP New York, NY10.9MShares$78.6 Million1.1% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.69MShares$26.7 Million0.08% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$24.9 Million7.08% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$19.3 Million0.35% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$19.2 Million0.12% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $214M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...